Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Advertisement
Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financ... "PR Newswire (US)" - 4/23/2015 4:15:00 PM
Baxter Submits Application To Japan's MHLW For Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For ... "PR Newswire (US)" - 4/16/2015 9:14:00 AM
Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference "PR Newswire (US)" - 4/13/2015 4:15:00 PM
Nektar Announces Receipt of $100 Million Milestone Payment from AstraZeneca "PR Newswire (US)" - 4/2/2015 9:35:00 AM
MOVANTIK™ (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pa... "PR Newswire (US)" - 3/31/2015 9:10:00 AM
Nektar-102 Will Be An Approved Treatment In Metastatic Breast Cancer "Seeking Alpha" - 3/23/2015 7:58:29 AM
AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US "PR Newswire (US)" - 3/19/2015 8:30:00 AM
Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Nektar Therapeutics "PR Newswire (US)" - 3/18/2015 3:53:00 PM
Why Nektar Therapeutics Stock Slumped Today "The Motley Fool" - 3/18/2015 11:56:43 AM
Premarket Gainers / Losers as of 9:10 am "Seeking Alpha" - 3/18/2015 9:12:28 AM
Nektar's NKTR-102 fails to demonstrate a significant increase in overall survival in breast cancer patients in Phase 3 study;... "Seeking Alpha" - 3/17/2015 6:29:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/17/2015 5:30:07 PM
Etirinotecan Pegol (NKTR-102) Prolonged Median Overall Survival by 2.1 Months versus Active Control in Patients with Advanced... "PR Newswire (US)" - 3/17/2015 4:15:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 2/26/2015 6:21:22 AM
Nektar Announces Start of Phase 3 SUMMIT-07 Study of NKTR-181 in Patients with Chronic Low Back Pain "PR Newswire (US)" - 2/25/2015 9:26:00 AM
Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2014 Results - Earnings Call Transcript "Seeking Alpha" - 2/24/2015 11:07:07 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2015 4:51:05 PM
Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results "PR Newswire (US)" - 2/24/2015 4:10:00 PM
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2014 on Tuesday, February 24, 2015, After Close of... "PR Newswire (US)" - 2/17/2015 4:15:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/13/2015 2:56:57 PM
Baxter Presents Additional Data From Pivotal Study Of BAX 855, Extended Half-life Investigational Recombinant FVIII Based On ... "PR Newswire (US)" - 2/11/2015 9:11:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/10/2015 11:32:33 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/6/2015 3:46:07 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/29/2015 2:22:39 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/26/2015 8:00:46 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist